Related Experiment Video
Updated: May 28, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Pulmonary complications of sickle cell disease
Ruby A Khoury1, Khaled M Musallam, Salman Mroueh
1Children's Cancer Centre of Lebanon, Department of Paediatrics and Adolescent Medicine, American University of Beirut, Medical Centre, Beirut, Lebanon.
Abstract:
The pulmonary complications of sickle cell disease are a major cause of morbidity and mortality in affected patients. The acute chest syndrome (ACS) is a leading cause of death in patients with sickle cell disease and has a multifactorial etiology. Hydroxyurea (HU), stem cell transplantation (SCT) and chronic transfusions are known to prevent the recurrence of ACS. Careful management of patients admitted for pain crises and surgery including use of incentive spirometry is critical in preventing this complication. Pulmonary hypertension is well known to be associated with sickle cell disease and patients with pulmonary hypertension have increased mortality. Asthma is also commonly seen in patients with sickle cell disease and is associated with a more complicated course. Chronic lung disease develops in a significant proportion of patients with sickle cell disease.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Edema II: Pathophysiology
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Pneumonia III: Complications and Assessment
